Goodspeed K et al. Current knowledge of SLC6A1-related neurodevelopmental disorders. Brain Commun. 2020;2(2):fcaa170. doi: 10.1093/braincomms/fcaa170. PMID: 33241211.
Johannesen KM et al. Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia. 2018;59(2):389-402. doi: 10.1111/epi.13986. PMID: 29315614
Johannesen KM et al. The phenotypic presentation of adult individuals with SLC6A1-related neurodevelopmental disorders. Front Neurosci. 2023;17:1216653. doi: 10.3389/fnins.2023.1216653. PMID: 37662110.
Kalvakuntla S et al. Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder. Front Neurosci. 2023;17:1024388. doi: 10.3389/fnins.2023.1024388. PMID: 36895422.
Kassabian B et al. Intrafamilial variability in SLC6A1-related neurodevelopmental disorders. Front Neurosci. 2023;17:1219262. doi: 10.3389/fnins.2023.1219262. PMID: 37502687.
Mermer F et al. Common molecular mechanisms of SLC6A1 variant-mediated neurodevelopmental disorders in astrocytes and neurons. Brain. 2021;144(8):2499-2512. doi: 10.1093/brain/awab207. PMID: 34028503.
Silva DB et al. Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants. Am J Hum Genet. 2024;111(6):1222-1238. doi: 10.1016/j.ajhg.2024.04.021. PMID: 38781976.
Stefanski A et al. SLC6A1 variant pathogenicity, molecular function and phenotype: a genetic and clinical analysis. Brain. 2023;146(12):5198-5208. doi: 10.1093/brain/awad292. PMID: 37647852.